Insider Trading activities of Rubius Therapeutics, Inc. (RUBY)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Rubius Therapeutics, Inc. (RUBY) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Rubius Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Rubius Therapeutics, Inc. since 2005. The reporting company's ticker symbol is RUBY. The reporting company's CIK number is 1709401.
The total value of stock buying since 2005 is $864,800.
The total value of stock sales since 2005 is $1,964,983.
The total value of stock option exercises since 2005 is $377,071.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Rubius Therapeutics, Inc. (RUBY).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-06 0 $0 47,757 $669,691 47,757 $137,062
2019-04 0 $0 22,196 $425,717 7,500 $1,125
2019-03 0 $0 48,000 $760,128 48,000 $137,760
2019-01 0 $0 7,500 $109,447 42,343 $101,124
2018-07 37,600 $864,800 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Rubius Therapeutics, Inc. insiders (RUBY)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-06-19 Carpenter Christopher L. (Chief Medical Officer) Sale 18,399 13.80 253,869
2019-06-19 Carpenter Christopher L. (Chief Medical Officer) Option Ex 18,399 2.87 52,805
2019-06-18 Carpenter Christopher L. (Chief Medical Officer) Sale 10,858 14.27 154,954
2019-06-18 Carpenter Christopher L. (Chief Medical Officer) Option Ex 10,858 2.87 31,162
2019-06-17 Carpenter Christopher L. (Chief Medical Officer) Sale 18,500 14.10 260,868
2019-06-17 Carpenter Christopher L. (Chief Medical Officer) Option Ex 18,500 2.87 53,095
2019-04-15 Langer Robert (Director) Sale 7,500 17.57 131,797
2019-04-15 Langer Robert (Director) Option Ex 7,500 .15 1,125
2019-04-08 Nissen Torben Straight (President) Sale 2,100 20.00 42,000
2019-04-05 Nissen Torben Straight (President) Sale 12,096 20.00 241,920
2019-04-03 Nissen Torben Straight (President) Sale 500 20.00 10,000
2019-03-15 Carpenter Christopher L. (Chief Medical Officer) Sale 48,000 15.84 760,128
2019-03-15 Carpenter Christopher L. (Chief Medical Officer) Option Ex 48,000 2.87 137,760
2019-01-22 Carpenter Christopher L. (Chief Medical Officer) Option Ex 34,843 2.87 99,999
2019-01-14 Langer Robert (Director) Sale 7,500 14.59 109,447
2019-01-14 Langer Robert (Director) Option Ex 7,500 .15 1,125
2018-07-20 Symonds Jonathan (Director) Buy 25,000 23.00 575,000
2018-07-20 Pomerantz Roger (Director) Buy 100 23.00 2,300
2018-07-20 Sohn Catherine A. (Director) Buy 2,500 23.00 57,500
2018-07-20 Cuss Francis M (Director) Buy 10,000 23.00 230,000

Insider trading activities including stock purchases, stock sales, and option exercises of RUBY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Rubius Therapeutics, Inc. (symbol RUBY, CIK number 1709401) see the Securities and Exchange Commission (SEC) website.